Jordan U. Gutterman, MD, Oral History Interview, April 19, 2012
Files
Download Full Interview Transcript (316 KB)
Loading...
Description
Major Topics Covered:
- Research: Avicins and nutrition
- Economics of clinical trials, drug testing; financial support for research
- Ethics
- The Department of Developmental Therapeutics
Major Topics Covered:
Personal and educational background
Mary Lasker: a personal friend and professional/financial supporter
Research: Interferon; success with patients; largest clinical trial; hairy-cell leukemia; tests on other cancers
Research: Avicins and nutrition
Economics of clinical trials, drug testing; financial support for research
Ethics
The Department of Developmental Therapeutics
Interview Chapters
Chapter 11: Funding Innovative Clinical Research: Some Institutional Obstacles
Chapter 12: Department Chair and Section Chief: Leadership Issues
Chapter 13: Going on Record with New Research: Avicins and Nutrition
Chapter 14: Establishing a New Research Focus: Experiments, Money, Organization
Identifier
GuttermanJ_03_20120419
Publication Date
4-19-2012
Publisher
The Historical Resources Center, Research Medical Library, The University of Texas Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Gutterman, Jordan U. MD and Rosolowski, Tacey A. PhD, "Jordan U. Gutterman, MD, Oral History Interview, April 19, 2012" (2012). Interview Sessions. 38.
https://openworks.mdanderson.org/mchv_interviewsessions/38
Conditions Governing Access
Redacted
About the Interview
About the Interview Subject:
Dr. Jordan U. Gutterman (born in Flandreau, South Dakota) came to MD Anderson in 1971 as a Senior Fellow in the Department of Developmental Therapeutics. He is currently Professor and Section Chief of the Department of Systems Biology. Dr. Gutterman is best known for discoveries arising from his work directing the world’s largest clinical study of interferon.
Interview Profile:
Over the course of three sessions conducted in 2012 (totaling approximately 5 hours), Dr. Jordan U. Gutterman (born in Flandreau, South Dakota) is interviewed as a follow up to three interviews conducted between 2004 and 2006 by Lesley Brunet. Tacey A. Rosolowski, Ph.D. interviews Dr. Gutterman in his office MD Anderson Cancer Center’s Research Park. Dr. Gutterman came to MD Anderson in 1971 as a Senior Fellow in the Department of Developmental Therapeutics. He is currently Professor and Section Chief of the Department of Systems Biology. Dr. Gutterman’s office is decorated with examples of his paintings –studies of vibrant color in acrylic paint. Also on display is the framed cover from the 30 March 1980 issue of Time Magazine, featuring the title: “Interferon: The IF Drug for Cancer.” Dr. Gutterman is best known for discoveries arising from his work directing the world’s largest clinical study of interferon.
Dr. Gutterman earned his BA in Liberal Arts at th e University of Virginia, Charlottesville (1960). His M.D. was conferred in 1964 by the Medical College of Virginia, Richmond. He went on to his Internship in Medicine at Duke Medical Center in Durham, North Carolina (1965), advancing to a Junior Assistant Residency and then a Hematology Fellowship. He then served as Chief Resident in Medicine at that same institution before coming to MD Anderson. Dr. Gutterman has received numerous awards, among them Milstein Award from the International Society for Interferon Research (1992).
In this interview, Dr. Gutterman discusses all dimensions of his work on interferon, from the research underpinnings and clinical challenges, to work of securing funding and dealing with celebrity. He talks about his family background and its influence on his beliefs about clinical care as well as nutrition. He also speaks for the first time on record about his work with avicins (derived from the acacia tree) and other plant substances with immuno-therapeutic properties.
Redaction Music:
Cylinder Five by Chris Zabriskie is licensed under a Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/)
Source: http://chriszabriskie.com/cylinders/ Artist: http://chriszabriskie.com/